VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm.
Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm. Ann Thorac Surg. 2019 01; 107(1):277-284.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Combined Modality Therapy
Disease-Free Survival
Female
Follow-Up Studies
Humans
Induction Chemotherapy
Lung Neoplasms
Male
Middle Aged
Neoplasm Staging
North America
Pneumonectomy
Radiotherapy, Adjuvant
Retrospective Studies
Survival Rate
Treatment Outcome
authors with profiles
STEPHEN G SWISHER
ARA A VAPORCIYAN
BORIS SEPESI